Y Liu, D Lin, B Wu, W Zhou - Brain research bulletin, 2016 - Elsevier
Ketamine is a noncompetitive antagonist of N-methyl-d-asparate (NMDA) receptor and has been long used as an anesthetic agent in humans and veterinary medicine. The present …
M Wang, Y Yang, CJ Wang, NJ Gamo, LE Jin… - Neuron, 2013 - cell.com
Neurons in the primate dorsolateral prefrontal cortex (dlPFC) generate persistent firing in the absence of sensory stimulation, the foundation of mental representation. Persistent firing …
Increasing preclinical and clinical evidence underscores the strong and rapid antidepressant properties of the glutamate-modulating NMDA receptor antagonist ketamine …
A Anticevic, M Gancsos, JD Murray… - Proceedings of the …, 2012 - National Acad Sciences
Glutamatergic neurotransmission mediated by N-methyl-d-aspartate (NMDA) receptors is vital for the cortical computations underlying cognition and might be disrupted in severe …
Despite great advances in basic neuroscience knowledge, the improved understanding of brain functioning has not yet led to the introduction of truly novel pharmacological …
Introduction Ketamine is attracting increasing research interest not only because of its powerful amnestic effects but also as a putative model of schizophrenia and as a substance …
Context Ketamine evokes psychosislike symptoms, and its primary action is to impairN- methyl-D-aspartate glutamate receptor neurotransmission, but it also induces secondary …
Modulating glutamatergic neurotransmission induces alterations in conscious experience that mimic the symptoms of early psychotic illness. We review studies that use intravenous …
Recent cognitive neuropsychiatric models of psychosis emphasize the role of attentional disturbances and inappropriate incentive learning in the development of deLusions. These …